ClinicalTrials.gg
Drug

Testosterone 17 beta-cypionate clinical trials

Also written Testosterone cypionate and Depo-Testosterone.

Its developmentBy Amneal Pharmaceuticals and Azurity Pharmaceuticals, step by step2 company-led studies, furthest phase 4: when each phase was reached, its deals, target and what is ahead.

A product of Testosterone; its studies count on that page too.

studies test it
27
open now
6
in phase 3
4
first study started
2008

How each study uses testosterone 17 beta-cypionate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the testosterone 17 beta-cypionate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Jun 1978 · TESTOSTERONE CYPIONATE · ANDA 086029 (FDA, Drugs@FDA)
European Union
28 Jul 2006 · Livensa · EMEA/H/C/000630 (EMA; as Testosterone; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

testosterone
5
depAndro
2
Depotest
2
Depovirin
2
Pertestis
2

Brand

Depo-Testosterone
6

Other names

Testosterone cypionate
17

Studies by the year they started

26 studies that test it; most in 2026 (5); 1 more planned to start later

Studies that test testosterone 17 beta-cypionate, by start year
YearStudies
20081
20111
20131
20152
20161
20171
20191
20203
20213
20222
20231
20242
20252
20265

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
12
Phase 3
4
Phase 4
7
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 25

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (4) · Brigham and Women's Hospital (2) · University of Miami (2) · VA Office of Research and Development (2) · University of California, San Diego (2) · Roswell Park Cancer Institute (1) · Emory University (1) · Leticia Maria Defendi Barboza Marson (1)

Often tested with

Tested in the same studies.

Leuprolide (2) · Darolutamide (2) · Testosterone enanthate (2) · Bupropion (1) · Anastrozole (1) · Danazol (1) · Chlorthalidone (1) · Enzalutamide (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test testosterone 17 beta-cypionate, phase 3 first.

Studies

Open first, then newest update. How each study uses testosterone 17 beta-cypionate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 27

See all 27 studies that test testosterone 17 beta-cypionate →

Given beside what is tested · 10 — testosterone 17 beta-cypionate is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 19, 2026.

Codes

What other systems call testosterone 17 beta-cypionate · ClinicalTrials.gg INT002641

  • MeSH (NLM) C016131testosterone 17 beta-cypionateConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) M0XW1UBI14TESTOSTERONE CYPIONATEConfirmed FDA, NLM
  • RxNorm 835827One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.